0.007488 0.000000 0.000803 0.000000 0.030989 0.000000 0.000000 0.000000 0.021831 0.00000 0.00000 0.00000 Ryu, S.E. Truneh, A. Sweet, R.W. Hendrickson, W.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 96.12 90.00 133.550 32.270 46.070 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 2 59 74 10.1016/S0969-2126(00)00008-3 8075984 Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 19826.518 T CELL SURFACE GLYCOPROTEIN CD4 1 man polymer no no TKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDS DTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTC TVLQNQKKVEFKIDIVVLA TKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDS DTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTC TVLQNQKKVEFKIDIVVLA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens 2.49 50.57 pdbx_database_status software software repository Initial release Version format compliance Version format compliance Data collection Other Refinement description Data collection Refinement description 1 0 1994-04-30 1 1 2008-03-24 1 2 2011-07-13 1 3 2019-07-17 1 4 2019-08-14 _pdbx_database_status.process_site _software.classification _software.classification Y BNL 1994-01-26 REL THR 0 n 1 THR 0 A LYS 1 n 2 LYS 1 A LYS 2 n 3 LYS 2 A VAL 3 n 4 VAL 3 A VAL 4 n 5 VAL 4 A LEU 5 n 6 LEU 5 A GLY 6 n 7 GLY 6 A LYS 7 n 8 LYS 7 A LYS 8 n 9 LYS 8 A GLY 9 n 10 GLY 9 A ASP 10 n 11 ASP 10 A THR 11 n 12 THR 11 A VAL 12 n 13 VAL 12 A GLU 13 n 14 GLU 13 A LEU 14 n 15 LEU 14 A THR 15 n 16 THR 15 A CYS 16 n 17 CYS 16 A THR 17 n 18 THR 17 A ALA 18 n 19 ALA 18 A SER 19 n 20 SER 19 A GLN 20 n 21 GLN 20 A LYS 21 n 22 LYS 21 A LYS 22 n 23 LYS 22 A SER 23 n 24 SER 23 A ILE 24 n 25 ILE 24 A GLN 25 n 26 GLN 25 A PHE 26 n 27 PHE 26 A HIS 27 n 28 HIS 27 A TRP 28 n 29 TRP 28 A LYS 29 n 30 LYS 29 A ASN 30 n 31 ASN 30 A SER 31 n 32 SER 31 A ASN 32 n 33 ASN 32 A GLN 33 n 34 GLN 33 A ILE 34 n 35 ILE 34 A LYS 35 n 36 LYS 35 A ILE 36 n 37 ILE 36 A LEU 37 n 38 LEU 37 A GLY 38 n 39 GLY 38 A ASN 39 n 40 ASN 39 A GLN 40 n 41 GLN 40 A GLY 41 n 42 GLY 41 A SER 42 n 43 SER 42 A PHE 43 n 44 PHE 43 A LEU 44 n 45 LEU 44 A THR 45 n 46 THR 45 A LYS 46 n 47 LYS 46 A GLY 47 n 48 GLY 47 A PRO 48 n 49 PRO 48 A SER 49 n 50 SER 49 A LYS 50 n 51 LYS 50 A LEU 51 n 52 LEU 51 A ASN 52 n 53 ASN 52 A ASP 53 n 54 ASP 53 A ARG 54 n 55 ARG 54 A ALA 55 n 56 ALA 55 A ASP 56 n 57 ASP 56 A SER 57 n 58 SER 57 A ARG 58 n 59 ARG 58 A ARG 59 n 60 ARG 59 A SER 60 n 61 SER 60 A LEU 61 n 62 LEU 61 A TRP 62 n 63 TRP 62 A ASP 63 n 64 ASP 63 A GLN 64 n 65 GLN 64 A GLY 65 n 66 GLY 65 A ASN 66 n 67 ASN 66 A PHE 67 n 68 PHE 67 A PRO 68 n 69 PRO 68 A LEU 69 n 70 LEU 69 A ILE 70 n 71 ILE 70 A ILE 71 n 72 ILE 71 A LYS 72 n 73 LYS 72 A ASN 73 n 74 ASN 73 A LEU 74 n 75 LEU 74 A LYS 75 n 76 LYS 75 A ILE 76 n 77 ILE 76 A GLU 77 n 78 GLU 77 A ASP 78 n 79 ASP 78 A SER 79 n 80 SER 79 A ASP 80 n 81 ASP 80 A THR 81 n 82 THR 81 A TYR 82 n 83 TYR 82 A ILE 83 n 84 ILE 83 A CYS 84 n 85 CYS 84 A GLU 85 n 86 GLU 85 A VAL 86 n 87 VAL 86 A GLU 87 n 88 GLU 87 A ASP 88 n 89 ASP 88 A GLN 89 n 90 GLN 89 A LYS 90 n 91 LYS 90 A GLU 91 n 92 GLU 91 A GLU 92 n 93 GLU 92 A VAL 93 n 94 VAL 93 A GLN 94 n 95 GLN 94 A LEU 95 n 96 LEU 95 A LEU 96 n 97 LEU 96 A VAL 97 n 98 VAL 97 A PHE 98 n 99 PHE 98 A GLY 99 n 100 GLY 99 A LEU 100 n 101 LEU 100 A THR 101 n 102 THR 101 A ALA 102 n 103 ALA 102 A ASN 103 n 104 ASN 103 A SER 104 n 105 SER 104 A ASP 105 n 106 ASP 105 A THR 106 n 107 THR 106 A HIS 107 n 108 HIS 107 A LEU 108 n 109 LEU 108 A LEU 109 n 110 LEU 109 A GLN 110 n 111 GLN 110 A GLY 111 n 112 GLY 111 A GLN 112 n 113 GLN 112 A SER 113 n 114 SER 113 A LEU 114 n 115 LEU 114 A THR 115 n 116 THR 115 A LEU 116 n 117 LEU 116 A THR 117 n 118 THR 117 A LEU 118 n 119 LEU 118 A GLU 119 n 120 GLU 119 A SER 120 n 121 SER 120 A PRO 121 n 122 PRO 121 A PRO 122 n 123 PRO 122 A GLY 123 n 124 GLY 123 A SER 124 n 125 SER 124 A SER 125 n 126 SER 125 A PRO 126 n 127 PRO 126 A SER 127 n 128 SER 127 A VAL 128 n 129 VAL 128 A GLN 129 n 130 GLN 129 A CYS 130 n 131 CYS 130 A ARG 131 n 132 ARG 131 A SER 132 n 133 SER 132 A PRO 133 n 134 PRO 133 A ARG 134 n 135 ARG 134 A GLY 135 n 136 GLY 135 A LYS 136 n 137 LYS 136 A ASN 137 n 138 ASN 137 A ILE 138 n 139 ILE 138 A GLN 139 n 140 GLN 139 A GLY 140 n 141 GLY 140 A GLY 141 n 142 GLY 141 A LYS 142 n 143 LYS 142 A THR 143 n 144 THR 143 A LEU 144 n 145 LEU 144 A SER 145 n 146 SER 145 A VAL 146 n 147 VAL 146 A SER 147 n 148 SER 147 A GLN 148 n 149 GLN 148 A LEU 149 n 150 LEU 149 A GLU 150 n 151 GLU 150 A LEU 151 n 152 LEU 151 A GLN 152 n 153 GLN 152 A ASP 153 n 154 ASP 153 A SER 154 n 155 SER 154 A GLY 155 n 156 GLY 155 A THR 156 n 157 THR 156 A TRP 157 n 158 TRP 157 A THR 158 n 159 THR 158 A CYS 159 n 160 CYS 159 A THR 160 n 161 THR 160 A VAL 161 n 162 VAL 161 A LEU 162 n 163 LEU 162 A GLN 163 n 164 GLN 163 A ASN 164 n 165 ASN 164 A GLN 165 n 166 GLN 165 A LYS 166 n 167 LYS 166 A LYS 167 n 168 LYS 167 A VAL 168 n 169 VAL 168 A GLU 169 n 170 GLU 169 A PHE 170 n 171 PHE 170 A LYS 171 n 172 LYS 171 A ILE 172 n 173 ILE 172 A ASP 173 n 174 ASP 173 A ILE 174 n 175 ILE 174 A VAL 175 n 176 VAL 175 A VAL 176 n 177 VAL 176 A LEU 177 n 178 LEU 177 A ALA 178 n 179 ALA 178 A author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 2_658 -x+1,y,-z+3 crystal symmetry operation 118.8152723676 0.0000000000 137.4223122408 1 A A N O GLN PHE 40 43 2.00 1 A A O N ASN LYS 164 166 2.07 1 13.39 2.20 113.40 126.79 A A A CA CB CG LYS LYS LYS 1 1 1 N 1 15.21 1.80 110.60 125.81 A A A N CA CB GLN GLN GLN 20 20 20 N 1 23.35 2.20 113.40 136.75 A A A CA CB CG GLN GLN GLN 20 20 20 N 1 14.67 1.90 110.30 124.97 A A A N CA CB THR THR THR 45 45 45 N 1 -5.94 0.90 118.30 112.36 A A A CB CG OD1 ASP ASP ASP 56 56 56 N 1 16.35 1.40 123.60 139.95 A A A CD NE CZ ARG ARG ARG 58 58 58 N 1 4.90 0.50 120.30 125.20 A A A NE CZ NH1 ARG ARG ARG 58 58 58 N 1 16.08 1.90 110.30 126.38 A A A N CA CB THR THR THR 81 81 81 N 1 -12.86 2.00 110.40 97.54 A A A N CA CB LEU LEU LEU 95 95 95 N 1 16.74 1.40 123.60 140.34 A A A CD NE CZ ARG ARG ARG 134 134 134 N 1 3.19 0.50 120.30 123.49 A A A NE CZ NH1 ARG ARG ARG 134 134 134 N 1 A LYS 1 -46.37 92.62 1 A ALA 18 -86.12 -82.75 1 A SER 19 85.71 21.99 1 A LYS 21 -30.21 128.06 1 A SER 31 -37.10 -35.74 1 A ASN 32 -64.04 22.59 1 A GLN 33 53.18 -17.75 1 A SER 49 176.12 154.16 1 A SER 60 -28.97 -44.14 1 A ASN 73 38.08 71.70 1 A ASP 78 -57.34 8.14 1 A GLU 87 35.73 -77.00 1 A ASN 103 -53.04 8.42 1 A SER 104 -111.77 -87.00 1 A ASP 105 173.02 -157.49 1 A SER 125 -116.85 60.51 1 A ILE 138 -169.21 101.08 1 A LEU 151 30.02 -58.52 1 A ASP 153 -88.70 37.92 1 A GLN 163 -117.48 -108.43 1 A GLN 165 54.14 -73.11 0.183 0.183 2.9 10 3235 1 4 2.9 10 0 1390 0 0 1390 0.013 0.440 1.000 0.796 1.500 0.545 1.500 0.910 2.000 model building X-PLOR refinement PROLSQ refinement X-PLOR phasing X-PLOR CD4 (D1D2 FRAGMENT) TYPE II CRYSTAL FORM STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES 1 N N A ARG 58 A ARG 59 HELX_P A GLY 65 A GLY 66 5 1 8 A LYS 75 A LYS 76 HELX_P A SER 79 A SER 80 5 2 5 A GLU 150 A GLU 151 HELX_P A SER 154 A SER 155 5 3 5 disulf 2.025 A CYS 16 A SG CYS 17 1_555 A CYS 84 A SG CYS 85 1_555 disulf 2.057 A CYS 130 A SG CYS 131 1_555 A CYS 159 A SG CYS 160 1_555 T-CELL SURFACE GLYCOPROTEIN T-CELL SURFACE GLYCOPROTEIN CD4_HUMAN UNP 1 1 P01730 MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRA DSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRG KNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKASSIVYKKEGEQVEFSFPLAFTVEKLTGSGELWW QAERASSSKSWITFDLKNKEVSVKRVTQDPKLQMGKKLPLHLTLPQALPQYAGSGNLTLALEAKTGKLHQEVNLVVMRAT QLQKNLTCEVWGPTSPKLMLSLKLENKEAKVSKREKAVWVLNPEAGMWQCLLSDSGQVLLESNIKVLPTWSTPVQPMALI VLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI 23 203 1CDI 0 178 P01730 A 1 1 179 1 GLY CONFLICT THR 0 1CDI A P01730 UNP 25 1 3 6 3 4 anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ARG 54 A ARG 55 A ARG 58 A ARG 59 A GLN 64 A GLN 65 A LYS 72 A LYS 73 A VAL 12 A VAL 13 A ALA 18 A ALA 19 A LYS 2 A LYS 3 A LYS 8 A LYS 9 A GLN 89 A GLN 90 A PHE 98 A PHE 99 A ASP 80 A ASP 81 A VAL 86 A VAL 87 A GLN 25 A GLN 26 A SER 31 A SER 32 A ILE 34 A ILE 35 A GLN 40 A GLN 41 A PHE 43 A PHE 44 A GLY 47 A GLY 48 A LYS 142 A LYS 143 A LEU 149 A LEU 150 A GLY 111 A GLY 112 A GLU 119 A GLU 120 A GLY 99 A GLY 100 A ASN 103 A ASN 104 A LYS 166 A LYS 167 A ILE 174 A ILE 175 A GLY 155 A GLY 156 A GLN 163 A GLN 164 A SER 127 A SER 128 A SER 132 A SER 133 A LYS 136 A LYS 137 A GLY 140 A GLY 141 5 C 1 2 1